Home / GLP-1 appeals / Ozempic / Cigna
Ozempic denial · Cigna
Cigna denied your Ozempic. Here is how to appeal it.
Most Cigna GLP-1 denials are winnable, if your appeal speaks to Cigna's own policy and lands before the deadline. We draft it for free, grounded in Cigna's actual coverage rules with every citation verified. You review, sign, and file it.
Free to draft. Every citation checked against Cigna's policy before you file.
Your deadline
Often 180 days
For Cigna's first-level internal appeal on commercial and ACA plans. Some plans allow longer. Your denial notice controls, check it.
Most common reason
Off-label for weight loss
If the claim reads as weight-loss use, Cigna may deny because Ozempic's on-label use is type 2 diabetes.
What wins
Demand the policy
Make Cigna name the exact coverage policy and confirm a real clinician reviewed your case, then meet each criterion.
Why Cigna denies Ozempic
Ozempic (semaglutide) is FDA-approved to improve blood sugar in adults with type 2 diabetes, and to reduce cardiovascular risk in adults with type 2 diabetes and known heart disease. Cigna, with pharmacy administered through Evernorth or Express Scripts on many plans, covers it behind prior authorization and often step therapy. Denials usually come down to a handful of patterns:
- Denied as off-label for weight loss. If the claim reads as weight-management use, Cigna may deny because Ozempic's on-label use is type 2 diabetes. The fix is to make the type 2 diabetes indication explicit in the record, with the diagnosis and supporting labs.
- Step therapy or fail-first. Many Cigna plans require a documented trial of metformin or other preferred agents before Ozempic. If your records do not show that trial clearly, the claim is denied even when the trial happened.
- Formulary tier or non-preferred status. Ozempic may sit on a non-preferred tier, which can trigger a denial or a higher-cost requirement until a preferred alternative is tried or shown to be unsuitable.
- Medical-necessity denial or a PxDx batch denial. Cigna evaluates these requests against a six-criterion medical-necessity standard, often without naming the specific coverage policy it applied. Cigna's PxDx system can also issue denials in batches without an individualized clinical review of your record, which is vulnerable to challenge on that ground.
How to win the appeal with Cigna
The pattern that works against Cigna is to refuse the black box: make them name the rule, confirm a real clinician looked at your case, then meet the policy on the record.
The move: in your appeal letter, demand that Cigna name the exact coverage policy and the six-criterion medical-necessity analysis it used, then flag any PxDx batch denial that lacked an individualized clinical review and ask whether a clinician actually reviewed your record. Make your type 2 diabetes indication explicit, then answer each criterion in order with the page of your record that proves it. A denial built without individualized review, or on a policy you were never shown, is a denial worth pressing.
- Make the diabetes indication explicit. If the denial treated this as weight-loss use, put the type 2 diabetes diagnosis and supporting labs front and center.
- Demand the specific policy Cigna applied and the six-criterion analysis behind it, then respond to each criterion directly.
- Confirm who issued the determination. Ask whether your denial received an individualized clinical review, and if a specialty vendor rather than a Cigna medical director issued it, that routing can create a procedural opening.
- Attach the documentation the policy asks for: the type 2 diabetes diagnosis, prior diabetes therapies tried, and relevant labs such as A1c, dated.
- File within the window. On Cigna commercial and ACA plans the first-level internal appeal is often due within 180 days of the denial, though some plans allow longer. If that is denied, you have the right to a further internal level where offered and then an independent external review.
- Use your federal appeal rights. Under the ACA you are entitled to a full internal appeal and then an external review by an independent reviewer. We map your appeal to those steps so nothing lapses.
Sources include Cigna's published coverage policy for GLP-1 agents and type 2 diabetes therapies and the Ozempic prescribing information. We cite the specific policy that applies to your plan when we build your appeal.
The magic is visible
Your appeal, built from Cigna's own rules. Every citation checked.
We draft from the sources below, then verify each one before you file. On our held-out testing: 0 invented citations, versus about 1 in 4 for raw AI.
- Cigna's coverage policyThe specific Cigna coverage policy for GLP-1 agents and type 2 diabetes therapies that applies to your planVerified
- FDA labelSemaglutide (Ozempic) prescribing information, indications and dosingVerified
- Your recordsYour type 2 diabetes diagnosis, prior diabetes therapies, and relevant labs (such as A1c), cited back accuratelyVerified
Let's check your Cigna denial, free.
Answer a few questions for an honest read on your odds, then your verified draft. No account, no cost.
Check my denial, freeCigna + Ozempic: common questions
How long do I have to appeal?
Do I need my doctor to appeal?
Why was my Ozempic denied as off-label or not medically necessary?
Is this really free?
Other Ozempic appeals: UnitedHealthcare · Anthem · Aetna · All Ozempic denials